In this work, the analysis of TRIB3 expression in a tissue microarray that was generated with samples from patients of luminal breast cancer revealed a clear correlation between high TRIB3 expression and higher DFS in this cohort that contained a majority of HER2− tumors. This evidence concerns the gene ERBB2 and breast cancer.